RE: Sales figures and other news8 Jun 2018 15:08
Alq - I get all that stuff, but being a simple kind a guy I ask why have they been faffing around for so long giving up exclusivity increasing the maximum production capacity to 8 million per annum, when by your estimations they may never even reach a need for one tenth of this capacity and in many years to come at that. So for first 3/4 years we might even have up to 80 x times the needed production capacity.
Reducing unit cost and transfer price is a function of scale and you are really suggesting that there is no meaningful scale, in which case I would expect to see the adjustment at the other end - retail price point..
I understand that pharma's agents typically send out to all and sundry taster documents which may or may not include detailed sales/market projections, and the negotiation process begins form there.
It was JG that said Recordati pitched much stronger numbers to RP, presumably to show they were a better option than a rival bidder. Anyway, its hardly that important.
There were sales in the UK without any marketing campaign whatsoever, although admittedly small, the compounding effect is a powerful one and I note Fortacin is available on line again in the UK.